Sponsors/CROs
Conduct Clinical Trials (CCT) is a high-performing Investigator Site Network (ISN), consisting of more than 5M+ active patients and 800 board-certified physicians who lead care in a broad spectrum of specialties.
Conduct Clinical Trials (CCT) is a well-known industry leader with 30 plus top pharma clients and more than 300 studies launched in every therapeutic area. Our high-performing Investigator Site Network (ISN), comprised of more than 500M+ active patients and 800 board-certified physicians, distinguished care providers in a broad spectrum of specialties.
CCT now offers the capability to conduct completely virtual trials with doctors trained in telemedicine. Our goal is to move your trial forward, whether virtually or on-site. Our Direct to Patient® integrated platform supports all systems and workflows of conducting virtual trials. We are your trusted partner for both centralized and decentralized trials.
Each independently owned and operated site is a large, community-based practice with a constant influx of patients, receiving treatment for countless conditions. The investigators are well-recognized industry thought leaders, making them invaluable resources and trusted experts for your clinical trials.
CCT is able to offer a diverse, searchable, patient population easily paired with appropriate trials, enhancing data reliability and study feasibility. We also offer a sophisticated and comprehensive new form of patient identity verification to protect against fraudulent participation in multiple studies. CCT has a well-established track record for providing the experienced personnel and streamlined technology necessary to get your product to market faster and more efficiently.
Rapid Access to a Network of Pre-qualified Research Sites
AI-Enabled Patient-Trial Matching
One Contract and One Budget for All Sites Selected on the Trial
“At Conduct Clinical Trials, We Believe Clinical Trials Are… Good for Doctors. Good for Patients. Good for Society.”
Michelle Alex, DPM
Only Conduct Clinical Trials can provide Direct to Patient® access through technology.